245 related articles for article (PubMed ID: 31015227)
21. Expression of CD133 cancer stem cell marker in melanoma: a systematic review and meta-analysis.
Madjd Z; Erfani E; Gheytanchi E; Moradi-Lakeh M; Shariftabrizi A; Asadi-Lari M
Int J Biol Markers; 2016 May; 31(2):e118-25. PubMed ID: 27102864
[TBL] [Abstract][Full Text] [Related]
22. Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine.
Zhao F; Zhang R; Wang J; Wu D; Pan M; Li M; Guo M; Dou J
Int Immunopharmacol; 2017 Nov; 52():238-244. PubMed ID: 28950176
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers.
Ekiz HA; Huffaker TB; Grossmann AH; Stephens WZ; Williams MA; Round JL; O'Connell RM
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30721153
[TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.
Fomeshi MR; Ebrahimi M; Mowla SJ; Khosravani P; Firouzi J; Khayatzadeh H
Cell Mol Biol Lett; 2015 Sep; 20(3):448-65. PubMed ID: 26208390
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
Wu Q; Guo R; Lin M; Zhou B; Wang Y
Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
[TBL] [Abstract][Full Text] [Related]
27. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
[TBL] [Abstract][Full Text] [Related]
28. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
29. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
30. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
[TBL] [Abstract][Full Text] [Related]
31. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
32. Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210.
Noman MZ; Janji B; Hu S; Wu JC; Martelli F; Bronte V; Chouaib S
Cancer Res; 2015 Sep; 75(18):3771-87. PubMed ID: 26206559
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.
Wang J; Yu F; Jia X; Iwanowycz S; Wang Y; Huang S; Ai W; Fan D
Int J Cancer; 2015 Mar; 136(6):E602-13. PubMed ID: 25143000
[TBL] [Abstract][Full Text] [Related]
34. Patient derived cell culture and isolation of CD133⁺ putative cancer stem cells from melanoma.
Welte Y; Davies C; Schäfer R; Regenbrecht CR
J Vis Exp; 2013 Mar; (73):e50200. PubMed ID: 23525090
[TBL] [Abstract][Full Text] [Related]
35. Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma.
Korn P; Kampmann A; Spalthoff S; Jehn P; Tavassol F; Lentge F; Gellrich NC; Zimmerer R
Asian Pac J Cancer Prev; 2021 May; 22(5):1591-1597. PubMed ID: 34048190
[TBL] [Abstract][Full Text] [Related]
36. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
Guo R; Wu Q; Liu F; Wang Y
Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969
[TBL] [Abstract][Full Text] [Related]
37. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
38. High intensity focused ultrasound enhances anti-tumor immunity by inhibiting the negative regulatory effect of miR-134 on CD86 in a murine melanoma model.
Yuan SM; Li H; Yang M; Zha H; Sun H; Li XR; Li AF; Gu Y; Duan L; Luo JY; Li CY; Wang Y; Wang ZB; He TC; Zhou L
Oncotarget; 2015 Nov; 6(35):37626-37. PubMed ID: 26485753
[TBL] [Abstract][Full Text] [Related]
39. MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells.
Xu K; Shen K; Liang X; Li Y; Nagao N; Li J; Liu J; Yin P
Oncotarget; 2016 Nov; 7(46):75118-75129. PubMed ID: 27738333
[TBL] [Abstract][Full Text] [Related]
40. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
Yu X; Mi L; Dong J; Zou J
BMC Cancer; 2017 Nov; 17(1):716. PubMed ID: 29110645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
